HuGE Literature Finder
Records
1
-
30
| CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence. BMC cancer 2022 8 22 (1): 884. Ambrozkiewicz Filip, Trailin Andriy, ?ervenková Lenka, Vaclavikova Radka, Hanicinec Vojtech, Allah Mohammad Al Obeed, Palek Richard, T?eška Vladislav, Daum Ondrej, Tonar Zbyn?k, Liška Václav, Hemminki Ka |
| Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes. Clinical lung cancer 2021 Aug . Seitlinger Joseph, Prieto Mathilde, Guerrera Francesco, Streit Arthur, Gauchotte Guillaume, Siat Joelle, Falcoz Pierre-Emmanuel, Massard Gilbert, Ferri Lorenzo, Spicer Jonathan, Renaud Stépha |
| Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan. JTO clinical and research reports 2021 9 2 (2): 100140. Wu Shang-Gin, Liao Wei-Yu, Su Kang-Yi, Yu Sung-Liang, Huang Yen-Lin, Yu Chong-Jen, Chih-Hsin Yang James, Shih Jin-Yu |
| Screening and Prognostic Value of Methylated Septin9 and its Association With Clinicopathological and Molecular Characteristics in Colorectal Cancer. Frontiers in molecular biosciences 2021 6 8 568818. Sun Jie, Xu Jinling, Sun Chao, Zheng Minying, Li Yuwei, Zhu Siwei, Zhang Shi |
| Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer. Journal of thoracic disease 2018 Mar 10 (3): 1788-1796. Mizuno Tetsuya, Arimura Takaaki, Kuroda Hiroaki, Sakakura Noriaki, Yatabe Yasushi, Sakao Yukino |
| Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients. Anticancer research 2017 04 37 (4): 2011-2018. Stotz Michael, Herzog Sereina A, Pichler Martin, Smolle Maria, Riedl Jakob, Rossmann Christopher, Bezan Angelika, Stöger Herbert, Renner Wilfried, Berghold Andrea, Gerger Arm |
| Copy number variations of neurotrophic tyrosine receptor kinase 3 (NTRK3) may predict prognosis of ovarian cancer. Medicine 2017 7 96 (30): e7621. Ge Li, Li Ning, Liu Mei, Xu Ning-Zhi, Wang Ming-Rong, Wu Ling-Yi |
| CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers. International journal of cancer 2017 09 141 (5): 967-976. Vedeld Hege Marie, Merok Marianne, Jeanmougin Marine, Danielsen Stine A, Honne Hilde, Presthus Gro Kummeneje, Svindland Aud, Sjo Ole H, Hektoen Merete, Eknaes Mette, Nesbakken Arild, Lothe Ragnhild A, Lind Guro |
| Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology 2016 Dec . Taieb J, Balogoun R, Le Malicot K, Tabernero J, Mini E, Folprecht G, Van Laethem J-L, Emile J-F, Mulot C, Fratté S, Levaché C-B, Saban-Roche L, Thaler J, Petersen L N, Bridgewater J, Perkins G, Lepage C, Van Cutsem E, Zaanan A, Laurent-Puig P, |
| The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis. BMC cancer 2016 16 (1): 120. Kim Hae Su, Heo Jin Seok, Lee Jeeyun, Lee Ji Yun, Lee Min-Young, Lim Sung Hee, Lee Woo Yong, Kim Seok Hyung, Park Yoon Ah, Cho Yong Beom, Yun Seong Hyeon, Kim Seung Tae, Park Joon Oh, Lim Ho Yeong, Choi Yong Soo, Kwon Woo Il, Kim Hee Cheol, Park Young S |
| LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy. The pharmacogenomics journal 2015 Oct 15 (5): 391-6. Szkandera J, Herzog S, Pichler M, Stiegelbauer V, Stotz M, Schaberl-Moser R, Samonigg H, Asslaber M, Lax S, Leitner G, Renner W, Lenz H-J, Berghold A, Gerger |
| Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma. Cancer 2015 Oct . Hakimi A Ari, Ostrovnaya Irina, Jacobsen Anders, Susztak Katalin, Coleman Jonathan A, Russo Paul, Winer Andrew G, Mano Roy, Sankin Alexander I, Motzer Robert J, Voss Martin H, Offit Kenneth, Purdue Mark, Pomerantz Mark, Freedman Matthew, Choueiri Toni K, Hsieh James J, Klein Robert |
| Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases. British journal of cancer 2015 Sep . Renaud Stéphane, Falcoz Pierre-Emmanuel, Schaëffer Mickaël, Guenot Dominique, Romain Benoit, Olland Anne, Reeb Jérémie, Santelmo Nicola, Chenard Marie-Pierre, Legrain Michèle, Voegeli Anne-Claire, Beau-Faller Michèle, Massard Gilbe |
| Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer. The pharmacogenomics journal 2015 Jun 15 (3): 226-34. Bohanes P, Yang D, Loupakis F, LaBonte M J, Gerger A, Ning Y, Lenz C, Lenz F, Wakatsuki T, Zhang W, Benhaim L, El-Khoueiry A, El-Khoueiry R, Lenz H |
| A subset of genetic susceptibility variants for colorectal cancer also has prognostic value. The pharmacogenomics journal 2015 May . Noci S, Dugo M, Bertola F, Melotti F, Vannelli A, Dragani T A, Galvan |
| Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2014 Dec 25 (12): 2378-85. Blons H, Emile J F, Le Malicot K, Julié C, Zaanan A, Tabernero J, Mini E, Folprecht G, Van Laethem J L, Thaler J, Bridgewater J, Nørgård-Petersen L, Van Cutsem E, Lepage C, Zawadi M A, Salazar R, Laurent-Puig P, Taieb |
| Association of common gene variants in the WNT/ß-catenin pathway with colon cancer recurrence. The pharmacogenomics journal 2014 Apr 14 (2): 142-50. Páez D, Gerger A, Zhang W, Yang D, Labonte M J, Benhanim L, Kahn M, Lenz F, Lenz C, Ning Y, Wakatsuki T, Loupakis F, Lenz H |
| Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy. The pharmacogenomics journal 2014 Apr 14 (2): 135-41. Benhaim L, Gerger A, Bohanes P, Paez D, Wakatsuki T, Yang D, Labonte M J, Ning Y, El-Khoueiry R, Loupakis F, Zhang W, Laurent-Puig P, Lenz H |
| The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy. The pharmacogenomics journal 2014 Apr 14 (2): 130-4. Absenger G, Benhaim L, Szkandera J, Zhang W, Yang D, Labonte M J, Pichler M, Stotz M, Samonigg H, Renner W, Gerger A, Lenz H |
| A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Mar 20 (6): 1687-97. Szkandera Joanna, Pichler Martin, Absenger Gudrun, Stotz Michael, Weissmueller Melanie, Samonigg Hellmut, Asslaber Martin, Lax Sigurd, Leitner Gerhard, Winder Thomas, Renner Wilfried, Gerger Arm |
| Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Molecular cancer therapeutics 2014 Feb 13 (2): 528-39. Ning Yan, Gerger Armin, Zhang Wu, Hanna Diana L, Yang Dongyun, Winder Thomas, Wakatsuki Takeru, Labonte Melissa J, Stintzing Sebastian, Volz Nico, Sunakawa Yu, Stremitzer Stefan, El-Khoueiry Rita, Lenz Heinz-Jos |
| Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer. Cancer research 2014 4 74 (11): 3084-91. Wang Chen, Cicek Mine S, Charbonneau Bridget, Kalli Kimberly R, Armasu Sebastian M, Larson Melissa C, Konecny Gottfried E, Winterhoff Boris, Fan Jian-Bing, Bibikova Marina, Chien Jeremy, Shridhar Viji, Block Matthew S, Hartmann Lynn C, Visscher Daniel W, Cunningham Julie M, Knutson Keith L, Fridley Brooke L, Goode Ellen |
| Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients. Cancer epidemiology 2013 Dec 37 (6): 1003-9. Szkandera Joanna, Absenger Gudrun, Liegl-Atzwanger Bernadette, Pichler Martin, Stotz Michael, Gerger Stefan, Zacherl Maximilian, Renner Wilfried, Haijun Miao, Leithner Andreas, Gerger Arm |
| Association of common gene variants in vitamin D modulating genes and colon cancer recurrence. Journal of cancer research and clinical oncology 2013 Sep 139 (9): 1457-64. Szkandera Joanna, Absenger Gudrun, Pichler Martin, Stotz Michael, Langsenlehner Tanja, Samonigg Hellmut, Renner Wilfried, Gerger Arm |
| A common gene variant in PLS3 predicts colon cancer recurrence in women. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Aug 34 (4): 2183-8. Szkandera Joanna, Winder Thomas, Stotz Michael, Weissmueller Melanie, Langsenlehner Tanja, Pichler Martin, Samonigg Hellmut, Renner Wilfried, Gerger Armin, Absenger Gudr |
| Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jun 31 (16): 2016-23. Phipps Amanda I, Shi Qian, Newcomb Polly A, Nelson Garth D, Sargent Daniel J, Alberts Steven R, Limburg Paul |
| Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer. Breast cancer research and treatment 2013 Apr 138 (3): 917-24. Murray James L, Thompson Patricia, Yoo Suk Young, Do Kim-Anh, Pande Mala, Zhou Renke, Liu Yanhong, Sahin Aysegul A, Bondy Melissa L, Brewster Abenaa |
| Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. PloS one 2013 8 (4): e60613. Smith David Hersi, Christensen Ib Jarle, Jensen Niels Frank, Markussen Bo, Rømer Maria Unni, Nygård Sune Boris, Müller Sven, Nielsen Hans Jørgen, Brünner Nils, Nielsen Kirsten Va |
| Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma. Hepatology (Baltimore, Md.) 2012 Oct . Dong QZ, Zhang XF, Zhao Y, Jia HL, Zhou HJ, Dai C, Sun HJ, Qin Y, Ren N, Ye QH, Qin LX |
| Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes. Cancer biomarkers : section A of Disease markers 2012 9 11 (2-3): 75-88. Cheol Kim Dae, Thorat Mangesh A, Lee Mi Ri, Cho Se Heon, Vasiljevi? Nataša, Scibior-Bentkowska Dorota, Wu Keqiang, Ahmad Amar S, Duffy Stephen, Cuzick Jack M, Lorincz Attila |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: